Redwood Investment Management LLC bought a new position in shares of Laboratory Co. of America Holdings (NYSE:LH – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 20,458 shares of the medical research company’s stock, valued at approximately $4,650,000. Other institutional investors […]
Laboratory Co. of America (NYSE:LH – Get Free Report) had its price target decreased by research analysts at JPMorgan Chase & Co. from $261.00 to $243.00 in a report issued on Thursday, Benzinga reports. The firm presently has an “overweight” rating on the medical research company’s stock. JPMorgan Chase & Co.‘s target price points to […]
Evoke Wealth LLC trimmed its holdings in Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 13.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 23,407 shares of the medical research company’s stock after selling 3,668 shares during the period. […]
Bank of Nova Scotia raised its position in Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 1,715.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 175,176 shares of the medical research company’s stock after buying an additional 165,528 […]
Paradigm Asset Management Co. LLC cut its holdings in Laboratory Co. of America Holdings (NYSE:LH – Free Report) by 1.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,401 shares of the medical research company’s stock after selling 100 shares […]